# A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure

> **NCT07230145** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing Suncadia Pharmaceuticals Co., Ltd** · enrollment: 48 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** SHR-4658 Injection.
- **DRUG:** SHR-4658 Placebo Injection

## Key facts

- **NCT ID:** NCT07230145
- **Lead sponsor:** Beijing Suncadia Pharmaceuticals Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11
- **Primary completion:** 2026-06
- **Final completion:** 2026-07
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07230145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07230145, "A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07230145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*